Europe Filgrastim
Market Report
2025
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024 and 2021 to 2024 will be historical period. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Europe Filgrastim Market Report 2023.
According to Cognitive Market Research, the global filgrastim market size was estimated at USD 565.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 169.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.4% from 2024 to 2031. In Europe, the market for filgrastim is witnessing steady growth driven by several factors. The increasing prevalence of cancer and other conditions requiring chemotherapy has heightened the demand for filgrastim, particularly in treating chemotherapy-induced neutropenia. The rise in the aging population across Europe contributes to the prevalence of chronic neutropenia, further boosting the market. The introduction of biosimilar filgrastim has also played a significant role in market expansion by offering cost-effective alternatives to the original biologic drug, thus improving accessibility and affordability for patients and healthcare systems. the presence of well-established healthcare infrastructure and reimbursement policies in European countries supports the adoption of filgrastim across various distribution channels, including hospital, retail, and online pharmacies. These channels provide convenient access to patients, contributing to market growth. Furthermore, ongoing research and development activities focusing on improving the efficacy and safety profiles of filgrastim variants continue to drive innovation in the region. In conclusion, the European filgrastim market exhibits promising growth prospects fueled by increasing demand for biologics and biosimilars. With a strategic focus on research and development and favorable government policies, the region is poised for sustained expansion in the coming years.
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Europe Filgrastim Market Sales Revenue 2024 | $ 169.56 Million |
Europe Filgrastim Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 1.4% |
Market Split by By Drug Type |
|
Market Split by By Distribution Channel: |
|
Market Split by By Indication |
|
List of Competitors | Competitors not disclose (Request Sample) |
Country Analysis | United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Rest of Europe | Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Europe Filgrastim industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Europe Filgrastim Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.
In the competitive landscape of pharmaceuticals, Abbott Laboratories, Amgen, Apotex, Cadila Pharmaceuticals, Dr. Reddy's Laboratories, Kirin Holding (Kyowa Kirin), Novartis, Pfizer, Teva Pharmaceutical Industries Ltd., and Toksöz Group stand as major players. Each company brings unique strengths in research, development, and manufacturing to the global market. They compete fiercely to introduce innovative drugs, expand market reach, and navigate regulatory challenges. Market dynamics, patent expirations, and emerging technologies constantly reshape this landscape, influencing companies' strategies and market positioning. Amidst this competition, maintaining a balance between innovation, cost-effectiveness, and regulatory compliance is crucial for sustained success.
In July 1, 2017, or as contracts permit, INEOS Calabrian will increase pricing for Sodium Metabisulfite by $0.03 per pound. This increase is due to a significant increase in market demand. (Source:https://www.ineos.com/businesses/ineos-enterprises/businesses/ineos-calabrian/news/ineos-calabrian-increases-pricing-for-its-sodium-metabisulfite/)
Top Companies Market Share in Europe Filgrastim Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The published report edition delivers Europe Market size analysis from 2019 till the forecast period of 2031. We have included analysis of top performing countries such as (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Rest of Europe) and their Market segmentation by By Drug Type, By Distribution Channel:, By Indication, etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.
Europe Filgrastim market By Drug Type size and share analysis, have been revealed under this section. This section offers market size, revenue share, y-o-y growth rate along with market attractiveness for each type. This will help you to understand which type held largest revenue share along with its compound annual growth rate (CAGR) of Europe Filgrastim Market.
With the help of type segment analysis, companies can understand which type has potential to invest along with its driving factors, current trends and other key factors. The timeline covered in the published North America Report edition is 2019 to 2031.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
By Distribution Channel: segment analysis is key parameter for key companies and new entrants offering versatile products or services, helping them customize products to meet the need of different user scenarios. Based on the application segment analysis, key companies can choose which application segments to target in the Europe Filgrastim Market. Our experts continuously monitor market dynamics and consumer trends of the each application to evaluate the attractiveness and potential of each segment. In terms of revenue, we can also provide the cross split of types in the each application for year 2021-2033. To understand more please connect with our sales team.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Europe then please revert us to access the exclusive Europe Filgrastim industry report Edition.
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Bio :Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare indust...Read More
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Europe Filgrastim Market is witnessing significant growth in the near future.
In 2023, the Biologic segment accounted for noticeable share of Europe Filgrastim Market and is projected to experience significant growth in the near future.
The Hospital pharmacies segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies , and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
By Drug Type | Biologic, Biosimilar |
By Distribution Channel: | Hospital pharmacies, Retail pharmacies, Online pharmacies |
By Indication | Chemotherapy-induced Neutropenia, Chronic Neutropenia |
List of Competitors | Not Disclosed! Request To Preview the List |
This chapter will help you gain Europe Market Analysis of Europe Filgrastim. Further deep in this chapter, you will be able to review Europe Europe Filgrastim Market Split by various segments and Country Split.
Chapter 1 Europe Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Europe Filgrastim. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 2 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 3 Qualitative Analysis (Subject to Data Availability)
Segmentation By Drug Type Analysis 2019 -2031, will provide market size split by By Drug Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 4 Market Split by By Drug Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 5 Market Split by By Distribution Channel: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 6 Market Split by By Indication Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Europe Filgrastim market
Chapter 7 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Biologic have a significant impact on Europe Filgrastim market? |
What are the key factors affecting the Biologic and Biosimilar of Europe Filgrastim Market? |
What is the CAGR/Growth Rate of Hospital pharmacies during the forecast period? |
By type, which segment accounted for largest share of the Europe Filgrastim Market? |
Which region is expected to dominate the Europe Filgrastim Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|